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ARTICLE
Acceleration of Stretch Activation in Murine Myocardium 
due to Phosphorylation of Myosin Regulatory Light Chain
Julian E. Stelzer, Jitandrakumar R. Patel, and Richard L. Moss
Department of Physiology, University of Wisconsin School of Medicine and Public Health, Madison, WI 53706
The regulatory light chains (RLCs) of vertebrate muscle myosins bind to the neck region of the heavy chain do-
main and are thought to play important structural roles in force transmission between the cross-bridge head and 
thick fi  lament backbone. In vertebrate striated muscles, the RLCs are reversibly phosphorylated by a specifi  c myo-
sin light chain kinase (MLCK), and while phosphorylation has been shown to accelerate the kinetics of force de-
velopment in skeletal muscle, the effects of RLC phosphorylation in cardiac muscle are not well understood. Here, 
we assessed the effects of RLC phosphorylation on force, and the kinetics of force development in myocardium 
was isolated in the presence of 2,3-butanedione monoxime (BDM) to dephosphorylate RLC, subsequently skinned, 
and then treated with MLCK to phosphorylate RLC. Since RLC phosphorylation may be an important determi-
nant of stretch activation in myocardium, we recorded the force responses of skinned myocardium to sudden 
stretches of 1% of muscle length both before and after treatment with MLCK. MLCK increased RLC phosphoryla-
tion, increased the Ca2+ sensitivity of isometric force, reduced the steepness of the force–pCa relationship, and 
  increased both Ca2+-activated and Ca2+-independent force. Sudden stretch of myocardium during an otherwise 
isometric contraction resulted in a concomitant increase in force that quickly decayed to a minimum and was fol-
lowed by a delayed redevelopment of force, i.e., stretch activation, to levels greater than pre-stretch force. MLCK 
had profound effects on the stretch activation responses during maximal and submaximal activations: the ampli-
tude and rate of force decay after stretch were signifi  cantly reduced, and the rate of delayed force recovery was ac-
celerated and its amplitude reduced. These data show that RLC phosphorylation increases force and the rate of 
cross-bridge recruitment in murine myocardium, which would increase power generation in vivo and thereby 
  enhance systolic function.
INTRODUCTION
The myosin molecule in vertebrate striated muscle is a 
hexamer comprised of two heavy chains ( 220 kD 
each) and two pairs of light chains ( 20 kD each) 
(Sweeney et al., 1993). The heavy chains have distinc-
tive α-helical regions in the head, neck, and tail do-
mains, while the two globular heads at the N terminus 
of the molecule contain ATP and actin binding sites. 
The light chain subunits include both essential light 
chains (ELCs) and regulatory light chains (RLCs), 
which bind to the neck region of the heavy chain and 
are thought to mechanically stabilize the α-helical lever 
arm during force transmission (Rayment et al., 1993). 
Consistent with this idea, selective removal of RLC has 
been shown to change the structure of cardiac myosin 
by altering the length of its globular region (Margossian 
and Slater, 1987). Furthermore, partial extraction of 
RLC from skinned skeletal muscle fi  bers reversibly in-
creased force at submaximal levels of activation (Moss 
et al., 1982; Hofmann et al., 1990) and abolished the 
Ca2+ dependence of the rate constant of force develop-
ment (ktr) after a release and restretch protocol (Patel 
et al., 1996).
In mammalian striated muscles, phosphorylation of 
RLC at residues near the N terminus by a Ca2+/calmodu-
lin (CaM)-dependent myosin light chain kinase (MLCK) 
increases force development by inducing movement of 
the myosin head away from the thick fi  lament backbone, 
which in turn increases the likelihood of its interaction 
with actin (Metzger et al., 1989; Levine et al., 1996; Yang 
et al., 1998). Previous work has shown that phosphoryla-
tion of RLC increases the Ca2+ sensitivity of force in 
skinned skeletal (Persechini et al., 1985; Metzger et al., 
1989; Sweeney and Stull, 1990; Szczesna et al., 2002;  Davis 
et al., 2002b) and cardiac muscles (Sweeney and Stull, 
1986; Morano et al., 1985, 1988; Sanbe et al., 1999; Pi 
et al., 2003; Olsson et al., 2004) and accelerates the rate of 
force development (ktr) in skinned skeletal muscle fi  bers 
at low levels of activation (Metzger et al., 1989; Sweeney 
and Stull, 1990). These results are consistent with the 
idea that phosphorylation increases the probability of in-
teraction between myosin and actin and accelerates bind-
ing and/or the transition to force generating states.
Correspondence to Julian E. Stelzer: stelzer@physiology.wisc.edu
Abbreviations used in this paper: BDM, 2,3-butanedione monoxime; 
IEF, iso-electric focusing; MLCK, myosin light chain kinase; RLC, 
  regulatory light chain.262 Regulatory Light Chain Phosphorylation in Murine Myocardium
The importance of RLC in cardiac function is evident 
from fi  ndings that mutations in RLC underlie some 
cases of hypertrophic cardiomyopathy (Poetter et al., 
1996; Flavigny et al., 1998; Andresen et al., 2001; 
Kabaeva et al., 2002; Richard et al., 2003; Szczesna-Cordary 
et al., 2005). Furthermore, based on fi  ndings that the 
expression and activity of MLCK systematically vary 
through the thickness of the ventricular free walls, it has 
been proposed that the spatial pattern of RLC phos-
phorylation in the heart is an important determinant of 
cardiac function (Davis et al., 2001, 2002b). Consistent 
with this idea, the phosphorylation state of RLC in skel-
etal muscle fi  bers (Davis et al., 2002b) has been shown 
to alter both the amplitude and the rate of stretch acti-
vation responses recorded during submaximal activa-
tions with Ca2+. Stretch activation is an intrinsic property 
of oscillatory muscles (Pringle, 1978), including myo-
cardium (Steiger, 1977), and is thought to play an im-
portant role in cardiac contraction and relaxation 
(Vemuri et al., 1999; Epstein and Davis, 2003, 2006; 
Campbell and Chandra, 2006). Our recent study (Stelzer 
et al., 2006b) showed that the amplitude and kinetics of 
the response to stretch in myocardium vary with the 
level of activating Ca2+, suggesting that the stretch-
  induced modulation of cardiac contraction varies on a 
beat-to-beat basis.
Based on studies using skeletal muscle fi  bers, it has 
been proposed that RLC phosphorylation modulates 
the work performed by the heart (Davis et al., 2001). 
The present study was undertaken to test this idea ex-
perimentally by examining the effects of RLC phos-
phorylation on the stretch activation response in murine 
myocardium and the sensitivity of these responses to Ca2+. 
Our results show that RLC phosphorylation has profound 
effects on cardiac muscle contractility by increasing the 
Ca2+ sensitivity of force and signifi  cantly accelerating 
the stretch activation response. These data support the 
idea (Davis et al., 2001) that previously observed that 
regional differences in RLC phosphorylation in the 
heart play an important role in determining the amount 
and rate of force generation across the ventricular wall, 
thereby modulating systolic ejection.
MATERIALS AND METHODS
Solutions
Solution compositions were calculated using the computer pro-
gram of Fabiato (Fabiato, 1988) and the stability constants listed 
by Godt and Lindley (1982) (corrected to pH 7.0 and 22°C). All 
solutions contained 100 mM N,N-bis(2 hydroxy-ethyl)-2-amino-
ethanesulfonic acid (BES), 15 mM creatine phosphate, 5 mM di-
thiothreitol, 1 mM free Mg2+, and 4 mM MgATP. In addition, pCa 
9.0 solution contained 7 mM EGTA and 0.02 mM CaCl2, pCa 4.5 
contained 7 mM EGTA and 7.01 mM CaCl2, and preactivating so-
lution contained 0.07 mM EGTA. Ionic strength of all solutions 
was adjusted to 180 mM with potassium propionate. Solutions 
containing different amounts of [Ca2+]free (i.e., pCa 6.2 to 5.4) 
were prepared by mixing appropriate volumes of pCa 9.0 and 
pCa 4.5. Smooth muscle MLCK was prepared as previously de-
scribed (Nagamoto and Yaki, 1984) and stored at −80°C until 
used in an experiment.
Skinned Myocardial Preparations
After i.p. injection of 5,000 U heparin/kg body weight, S129 mice 
of either sex (3–6 mo old) were anesthetized with inhaled isofl  u-
rane (15% isofl  urane in mineral oil) in accordance with the ani-
mal care guidelines of the University of Wisconsin School of 
Medicine and Public Health. The hearts were excised and right 
and left ventricles were dissected free in Ringer’s solution (120 mM 
NaCl, 19 mM NaHCO3, 10 mM glucose, 5 mM KCl, 1.2 mM 
MgSO4, 1.2 mM Na2HPO4, 1 mM CaCl2; pH 7.4; 22°C) and pre-
equilibrated with 95% O2/5% CO2. The tissue was pinned to the 
bottom of the dissecting dish and perfused with fresh Ringer’s so-
lution containing 30 mM 2,3-butanedione monoxime (BDM), a 
compound that acts as a chemical phosphatase (Wiggins et al., 
1980) and has been shown to dephosphorylate RLC in myocar-
dium (Turnbull et al., 2002; Olsson et al., 2004). Treatment of 
cardiac tissue with BDM was necessary in order to ensure that all 
preparations chosen for experiments will have a homogeneous 
RLC phosphorylation profi  le, as it has been previously shown that 
regional differences in RLC phosphorylation levels exist in mu-
rine hearts (Davis et al., 2001). After a 30-min incubation with 
BDM, heart tissue was frozen in liquid nitrogen and stored at 
−80°C until the day of the experiment.
On the day of the experiment, skinned myocardium was pre-
pared by the thawing the frozen ventricles and homogenizing for 
 2 s in relaxing solution (100 mM KCl, 20 mM imidazole, 7 mM 
MgCl2, 2 mM EGTA, and 4 mM MgATP; pH 7.0) using a Polytron 
homogenizer, which yielded multicellular preparations of 100–
250 μm × 600–900 μm. The homogenate was centrifuged at 120 g 
for 1 min, and the resulting pellet was washed with fresh relaxing 
solution and resuspended in relaxing solution containing 250 μg 
saponin/ml and 1% Triton X-100. After 30 min, the skinned 
preparations were washed with fresh relaxing solution and were 
dispersed in  50 ml relaxing solution in a glass Petri dish. The 
dish was kept on ice except during the selection of individual 
preparations for mechanical experiments.
Apparatus and Experimental Protocol
Skinned preparations with well-defi  ned edges were transferred 
from the Petri dish to a stainless steel experimental chamber 
(Stelzer et al., 2004) containing relaxing solution. The ends of 
each preparation were attached to the arms of a motor (model 
312B; Aurora Scientifi  c Inc.) and force transducer (model 403; 
Aurora Scientifi  c Inc.), as described earlier (Stelzer et al., 2004). 
The chamber assembly was then placed on the stage of an in-
verted microscope (Carl Zeiss MicroImaging, Inc.) fi  tted with a 
40× objective and a CCTV camera (model WV-BL600,  Panasonic). 
Bitmap images of the preparations were acquired using an AGP 
4X/2X graphics card and associated software (ATI Technologies 
Inc.) and were used to assess mean sarcomere length (SL) during 
the course of each experiment. Changes in force and motor 
  position were sampled (16-bit resolution, DAP5216a, Microstar 
Laboratories) at rates ≥2.0 kHz using SLControl software 
  developed in our laboratory (Campbell and Moss, 2003) and 
saved to computer fi  les for later analysis. Fiber force during the 
experiments was also recorded on a digital oscilloscope (Nicolet 
Instrument Corporation).
At the start of each experiment, the preparation was stretched 
to a mean sarcomere length of  2.2 μm for measurements of 
steady-state Ca2+-activated force, which was measured as the dif-
ference between total force and resting force at each pCa studied. 
The preparation was initially activated at pCa 4.5 to determine 
maximum Ca2+-activated force (Po). A force–pCa relationship 
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varying pCa (6.2–4.5), and once steady tension had developed, 
the muscle was slackened to reduce force to zero. Normalized 
force–pCa relationships were generated by expressing submaxi-
mal force (P) at each pCa as a fraction of maximal force (Po) 
measured in the same preparation at pCa 4.5, i.e., P/Po. Apparent 
cooperativity of force development was inferred from the steep-
ness of the force–pCa relationship, which was quantifi  ed using a 
Hill plot transformation of the data (Stelzer et al., 2004).
Force–pCa relationships were also generated using skinned 
cardiac preparations that were subjected to a protocol to phos-
phorylate RLC. These preparations were incubated for 10 min in 
preactivating solution containing 5 mM BDM (to inhibit force de-
velopment); for 30 min in preactivating solution containing 5 
mM BDM, 67 μM CaCl2, 6 μM calmodulin, and 0.4 μM smooth 
muscle MLCK (to phosphorylate RLC); and then for 30 min 
(three solution changes) in solution of pCa 9.0 to wash out MLCK 
(Olsson et al., 2004). BDM acts as a phosphatase in the intact 
heart but not in isolated skinned myocardium (Olsson et al., 
2004). Control experiments performed in the present study and 
in previous studies (Olsson et al., 2004) have shown that incuba-
tion of skinned cardiac fi  bers with BDM alone does not alter RLC 
phosphorylation levels or contractile function.
For stretch activation experiments, sarcomere length was ini-
tially set at  2.2 μm and preparations were activated at pCa 4.5 to 
determine maximal Ca2+-activated force and pCa 9.0 to deter-
mine Ca2+-independent resting force. Stretch activation responses 
were fi  rst assessed at three levels of activation in preparations in 
which RLC was not phosphorylated, i.e., in solutions yielding 
maximum force (pCa 4.5),  50% of maximum force (pCa 
 5.75), and  25% of maximum force (pCa  5.85). Once steady-
state force was reached, a rapid stretch of 1% of preparation 
length (Lo) was imposed and held for 5 s before returning the 
preparation to solution of pCa 9.0. This protocol was then 
  repeated on the same fi  bers after incubation with MLCK, as 
  described above.
The stretch activation variables were measured as previously 
described (Stelzer et al., 2006b). All amplitudes were normalized 
to prestretch Ca2+-activated isometric force to allow comparisons 
between different levels of activation. Amplitudes were measured 
as follows: P1, measured from prestretch steady-state force to the 
peak of phase 1, P2, measured from prestretch isometric force to 
the minimum force at the end of phase 2, P3, measured from pre-
stretch isometric force to the peak of delayed force in phase 3, 
and Pdf, the difference between P3 and P2. Apparent rate constants 
were derived for phase 2 (krel, s−1) and for phase 3 (kdf, s−1) from 
the point of force reuptake after phase 2 to the completion of 
  delayed force development.
At the conclusion of the mechanical experiment, the prepara-
tion was cut free at the points of attachment and placed in 
  rehydration/sample buffer (Bio-Rad Laboratories). The samples 
were then stored at −80°C until subsequent analysis of RLC phos-
phorylation state using two-dimensional gel electrophoresis in a 
mini gel system (Bio-Rad Laboratories) as previously described 
(Olsson et al., 2004). In brief, the fi  rst dimensional iso-electric 
focusing (IEF) tube gels containing 8 mM urea, 4% acrylamide-
bisacrylamide (30% acrylamide/bisacrylamide solution; Bio-Rad 
Laboratories), 2% Triton X-100, 2% ampholyte (pH 4.1–5.9; 
Bio-Rad Laboratories), 0.02% ammonium persulfate, and 0.2% 
TEMED were prefocused fi  rst at 200 V for 15 min and then at 
400 V for 15 min. The samples were then loaded onto the gels 
and electrofocused fi  rst at 500 V for 20 min and then at 750 V for 
4 h 40 min. The IEF tube gels were ejected onto a 12.5% Tris-HCL 
Criterion Precast gel (Bio-Rad Laboratories) and electrophoresed 
at 150 V for 1 h 30 min. The gels were then silver stained at room 
temperature using published methods (Shevchenko et al., 1996) 
with minor modifi  cations, as follows: the gels were (a) incubated 
in fi  xing solution containing 50% methanol and 10% acetic acid 
for 20 min, (b) washed with distilled water for 20 min (4× water 
change), (c) incubated in 0.01% sodium thiosulfate solution for 
1.5 min and then rinsed 4× with distilled water, (d) incubated 
in 0.09% silver nitrate solution for 20 min and then rinsed 4× 
with distilled water, (e) incubated in developing solution contain-
ing 0.0004% sodium thiosulfate, 2% potassium carbonate, and 
0.0068% formaldehyde until proteins were visible and then rinsed 
4× with distilled water, (f) incubated in destaining solution con-
taining 10% methanol and 10% acetic acid for 20 min, rinsed 4× 
in distilled water, and fi  nally rinsed (with slow rotation) overnight 
in distilled water. The gels were then dried between two sheets of 
cellophane overnight, and the percent RLC phosphorylation was 
quantifi  ed using UVP Bio  Imaging System and LaserPix software 
(Bio-Rad Laboratories).
Data Analysis
Cross-sectional areas of skinned preparations were calculated by 
assuming that the preparations were cylindrical and by equating 
the width, measured from video images of the mounted prepara-
tions, to diameter. Each submaximal Ca2+-activated force (P) was 
expressed as a fraction of the maximum Ca2+-activated force (Po) 
generated by the same preparation at pCa 4.5, i.e., P/Po. To deter-
mine the Ca2+ sensitivity of isometric force (pCa50), the force–pCa 
data were fi  tted with the Hill equation: P/Po = [Ca2+]n/(kn + 
[Ca2+]n)], where n is the slope (Hill coeffi  cient) and k is the Ca2+ 
concentration required for half-maximal activation.
Analysis of stretch activation data was performed as previously 
described (Stelzer et al., 2006b). In brief, rate constants of force 
decay (krel) were obtained by fi  tting a single exponential to the 
time course of decay, i.e., y = a (1 − exp (−k1 · x)), where “a” is 
the amplitude of the single exponential phase and k1 is the rate 
constant of decay. Rate constants of delayed force development 
in phase 3 were estimated either with a double exponential fi  t, 
y = a · exp(−k1 · x) + b · exp(−k2 · x), where “a” is the amplitude 
of the fi  rst exponential phase rising with rate constant k1, and “b” 
is the amplitude of the second exponential phase rising with rate 
constant k2, or were estimated as a single composite rate constant 
Figure 1.  Myosin regulatory light chain (RLC) 
phosphorylation of murine skinned myocardium. 
Two-dimensional SDS-PAGE/IEF gels were used 
to determine levels of RLC phosphorylation in 
skinned myocardium. The gel on the left shows 
that BDM treatment resulted in no detectable 
RLC phosphorylation, while the gel on the right 
shows that subsequent treatment with MLCK 
phosphorylated a signifi   cant fraction of RLC. 
Densitometric scans of the two RLC spots in the 
gel on the right indicated that 39% of total RLC 
was phosphorylated. Other spots represent tropo-
myosin (Tm) and essential light chain (ELC).264 Regulatory Light Chain Phosphorylation in Murine Myocardium
by linear transformation of the half-time of force redevelopment, 
i.e., (kdf = −ln 0.5 × [t1/2]−1) (Stelzer et al., 2006b).
All data are reported as means ± SEM. Statistical analysis was 
done using a repeated measures analysis of variance (ANOVA) 
and a Tukey post-hoc test where appropriate, and P values <0.05 
were taken as indicating signifi  cant differences.
RESULTS
Effect of RLC Phosphorylation on Ca2+ Sensitivity of Force
The preparations used in this study were isolated from 
murine hearts that were fi  rst incubated in the presence 
of BDM in order to dephosphorylate RLC and thereby 
establish a uniformly low baseline level of RLC phos-
phorylation before mechanical measurements. Fig. 1 A 
is a two-dimensional (PAGE vs. IEF) gel of a skinned 
myocardial preparation treated in this way, demonstrat-
ing that this protocol was effective in reducing RLC 
phosphorylation in skinned cardiac preparations to 
near zero, i.e., no RLC phosphorylation was detected 
with our BioImaging system. Subsequent treatment of 
these preparations with MLCK, as described in Materi-
als and methods, resulted in phosphorylation of RLC to 
an average of 38 ± 3% (n = 7) of total light chain, as 
shown in the two-dimensional gel in Fig. 1 B. This level 
of phosphorylation is close to values that have been re-
ported for living myocardium (Morano, 1999; van der 
Velden et al., 2003) and also to values reported previ-
ously in skinned myocardium treated with MLCK (Sanbe 
et al., 1999; Olsson et al., 2004).
Treatment of the skinned preparations with MLCK 
increased maximal Ca2+-activated (pCa 4.5) force by 
 40% and increased Ca2+-independent (pCa 9.0) rest-
ing force by  100% (Table I). Force–pCa relationships 
measured in skinned myocardium both before and af-
ter MLCK treatment were sigmoidal and were fi  t well 
with the Hill equation (Fig. 2). Phosphorylation of RLC 
increased the Ca2+ sensitivity of force, i.e., pCa50 in-
creased from 5.71 ± 0.01 to 5.83 ± 0.01 (P < 0.01, 
Table I) after MLCK treatment, thus reducing the Ca2+ 
concentration required to evoke a given submaximal 
force. The steepness of the force–pCa relationship, 
which is an indicator of the apparent cooperativity of 
force development, was markedly reduced after MLCK 
treatment, in that the Hill coeffi  cient (nH) decreased 
from 3.79 ± 0.23 before treatment to 3.22 ± 0.26 after 
treatment (P < 0.01, Table I).
Effects of RLC Phosphorylation on the Stretch Activation 
Response of Murine Skinned Myocardium
The records in Fig. 3 exemplify the stretch activation re-
sponse to a 1% increase in preparation length at an 
  activation level of  50% of maximal and in the absence 
of RLC phosphorylation. The multiphasic response to 
stretch of an otherwise isometrically contracting prepa-
ration starts with an increase in force (phase 1) coinci-
dent with the stretch, which is followed by a rapid decay 
in force (phase 2), which reaches a minimum (P2) be-
fore force recovers (phase 3, delayed force rise) to a 
level (P3) greater than the prestretch isometric force 
and then eventually decays back to the prestretch level.
RLC phosphorylation resulted in signifi  cant changes 
to the stretch activation response of skinned myocar-
dium, as shown in the records of Fig. 4 in which a stretch 
of 1% of initial muscle length was imposed during an 
activation that was  50% maximal (pCa 5.75). RLC 
phosphorylation evoked a large increase in prestretch 
isometric force and altered the stretch activation 
  response (Fig. 4). To allow direct comparisons of the 
effects of RLC phosphorylation on stretch activation 
Figure 2.  Effect of RLC phosphorylation on force-pCa relation-
ships. RLC phosphorylation increased the Ca2+ sensitivity force 
and decreased cooperative activation of force development: fi  tted 
values for nH and pCa50 were 3.79 ± 0.23 and pCa 5.71 ± 0.01 for 
untreated myocardium (−MLCK ●, n = 10) and 3.22 ± 0.26 and 
pCa 5.83 ± 0.01 for MLCK-treated myocardium (+MLCK  ○, 
n = 10). Data points are means ± SEM. Forces measured at sub-
maximal free Ca2+ concentration ([Ca2+]free) were expressed rela-
tive to the maximal force obtained at pCa 4.5. The smooth lines 
were fi  t using the Hill equation: P/Po = [Ca2+]n/(kn + [Ca2+]n)], 
where P is the force measured at submaximal [Ca2+]free, Po is 
the force measured at maximal [Ca2+]free (pCa 4.5), nH is the Hill 
coeffi  cient, and k is the Ca2+ concentration required for half-
  maximal activation.
TABLE I
Effect of MLCK Treatment on Steady-state Contractile Properties 
of Murine Myocardium
Group Fmax Fmin pCa50 nH
mN/mm2 mN/mm2
−MLCK 15.5 ± 0.8 0.7 ± 0.2 5.71 ± 0.01 3.79 ± 0.23
+MLCK 21.7 ± 1.3a 1.4 ± 0.4a 5.83 ± 0.01a 3.22 ± 0.26a
Data are means ± SEM from 10 preparations. Fmax, maximum Ca2+-
activated force at pCa 4.5; Fmin, Ca2+-independent force at pCa 9.0; pCa50, 
pCa required for half-maximal force; nH, Hill coeffi  cient for force–pCa 
relationship.
aSignifi  cantly different from data obtained −MLCK, P < 0.05.  Stelzer et al. 265
variables, traces obtained at different levels of Ca2+ acti-
vation were normalized to prestretch isometric force 
(Fig. 5), which is expressed as a “zero” baseline. As re-
ported previously (Stelzer et al., 2006b), increases in 
Ca2+ activation accelerated the overall rate of the stretch 
activation response and reduced its amplitude (normal-
ized to prestretch isometric force) (Stelzer et al., 2006b). 
After RLC phosphorylation, the amplitude of the stretch 
activation response (phase 3) at each level of activation 
was reduced and delayed force reached a maximum 
more quickly, with the most prominent effects occur-
ring at submaximal levels of activation (Fig. 5). Super-
imposing normalized stretch activation traces obtained 
from the same fi  ber before (−MLCK) and following 
(+MLCK) RLC phosphorylation (Fig. 6 A) clearly 
shows these differences. We also examined the effect of 
RLC phosphorylation on the stretch activation response 
as a function of relative maximal force, i.e., P/Po. 
The trace shown (Fig. 6 B) for the RLC phosphorylated 
preparation was obtained using a decreased [Ca2+] 
compared with the RLC nonphosphorylated prepara-
tion; however, it can be seen that the stretch activation 
response was still accelerated after RLC phosphoryla-
tion as when plotted at the same [Ca2+] (Fig. 6 A). The 
amplitude (P1) of phase 1 increased as a function of in-
creasing prestretch isometric force and did not differ 
signifi  cantly with RLC phosphorylation (unpublished 
data), at least within the frequency response of our 
force transducer.
In both the presence and absence of RLC phosphory-
lation, reducing the level of prestretch activation by re-
ducing the [Ca2+] slightly accelerated the rapid force 
decay in phase 2 (krel). Phase 2 is thought to represent 
detachment of cross-bridges that are strained by stretch 
and their rapid replacement by unstrained cross-bridges 
(Davis and Rodgers, 1995; Piazzesi et al., 1997) and was 
substantially slower at all levels of activation after RLC 
phosphorylation (Fig. 7). This result is consistent with 
earlier reports (Patel et al., 1998; Davis et al., 2002b) 
that RLC phosphorylation slowed the rate of relaxation 
in skinned skeletal fi  bers. Furthermore, RLC phosphor-
ylation signifi  cantly reduced the amount of force decay 
during phase 2 (Figs. 6 and 7), such that delayed force 
recovery (phase 3) began from a higher force (P2) and 
the overall amplitude of the phase 3 delayed force tran-
sient (i.e., trough to peak excursion, Pdf) was signifi  -
cantly reduced (Fig. 8).
The delayed recruitment of cross-bridges due to 
stretch is highly dependent on the level of prestretch 
force (Linari et al., 2004; Stelzer et al., 2006b) and de-
termines the amplitude (Pdf) of phase 3. Both before 
and after phosphorylation of RLC, Pdf was inversely pro-
portional to activation level (Stelzer et al., 2006b), such 
that relatively fewer cross-bridges were recruited by 
Figure 3.  Stretch activation response in murine 
myocardium. The force transient shown (bottom 
panel) is typical of the stretch activation re-
sponses of WT myocardium after a stretch of 1% 
of muscle length (top panel). Once a steady-state 
isometric force of  50% of maximal was achieved 
in the presence of Ca2+, the muscle was stretched 
and then held at the longer length, as described 
in Materials and Methods. The recorded vari-
ables are labeled on the force record and de-
scribed in the text.266 Regulatory Light Chain Phosphorylation in Murine Myocardium
stretch as the level of activation was increased. RLC 
phosphorylation decreased the amplitude of Pdf at each 
level of activation studied (Fig. 8), primarily as a conse-
quence of the effects of phosphorylation to increase P2, 
the baseline from which Pdf was measured.
Delayed force development (phase 3) after stretch is 
generally thought to involve the recruitment of cross-
bridges into strongly bound states (Lombardi and 
  Piazzesi., 1990; Piazzesi et al., 1997; Campbell et al., 2004), 
and, as previously reported (Linari et al., 2004; Stelzer 
et al., 2006b), does not occur as a simple exponential 
process and is therefore not well fi  t with a single expo-
nential equation, especially at low levels of activation. 
To facilitate comparisons of phase 3 rates of force devel-
opment at different levels of activation, a composite ap-
parent rate constant (kdf) of delayed force development 
was calculated from the half-time of force development. 
Consistent with earlier reports (Stelzer et al., 2006a,b), 
kdf in murine myocardium was accelerated by increasing 
the level of activation (Table II; Fig. 8), which was also 
the case after RLC phosphorylation. However, RLC 
phosphorylation accelerated kdf at all levels of activa-
tion, with the greatest effects observed at low levels of 
activation (Fig. 8; Table II).
The kinetics of delayed force development were also 
analyzed with a double exponential fi  t, which yielded 
fast and slow rate constants (k1 and k2) and their corre-
sponding amplitudes (a and b), as shown in Table II. 
Prior to MLCK treatment, decreasing the level of activa-
tion progressively increased the amplitude (b) of the 
slower rate process (thought to manifest cooperative re-
cruitment of cross-bridges) and decreased its apparent 
rate (k2) (Stelzer et al., 2006a,b). After MLCK treat-
ment, delayed force development occurred as a single 
exponential process at all levels of activation (Table II), 
such that the slower rate process (k2) was absent. RLC 
phosphorylation accelerated force development at each 
level of activation (Fig. 8; Table II), but again, these ef-
fects were greatest at the lowest levels of activation stud-
ied (Table II). Since the slower phase of delayed force 
development appears to manifest cooperative recruit-
ment of cross-bridges to force generating states, which 
is most prominent at low levels of activation (Moss, 
et al., 2004), RLC phosphorylation presumably either 
accelerates or eliminates this recruitment process.
DISCUSSION
Effect of RLC Phosphorylation on Isometric Force 
and the Ca2+ Sensitivity of Force
A consistent observation in previous studies is that phos-
phorylation of RLC in both skeletal (Persechini et al., 
1985; Metzger et al., 1989; Sweeney and Stull, 1990; 
  Szczesna et al., 2002; Davis et al., 2002b) and cardiac 
(Sweeney and Stull, 1986; Morano et al., 1985, 1988; 
Sanbe et al., 1999; Pi et al., 2003; Olsson et al., 2004) 
muscles causes an increase in the Ca2+ sensitivity of 
force, which was also observed here (Fig. 2). Such  effects 
are presumably the result of increased probability of 
cross-bridge binding to actin as a result of phosphory-
lation (Metzger et al., 1989; Sweeney and Stull, 1990), 
most likely due to increased radial dispersion of the 
  myosin heads (Levine et al., 1998; Morano, 1999). RLC 
phosphorylation increased both resting force at pCa 9.0 
and maximal force at pCa 4.5, while decreasing the 
overall steepness of the force–pCa relationship, suggest-
ing an increase in cross-bridge binding both in the ab-
sence and presence of Ca2+. Phosphorylation-dependent 
increases in maximal force have been observed by 
Figure 4.  Effect of RLC phosphorylation on 
the force transients produced by stretch. Force 
responses of skinned myocardium to a stretch of 
1% of muscle length applied during isometric 
contractions ( 50% of maximal, pCa 5.75) were 
recorded in an untreated preparation (−MLCK, 
bottom trace) and in the same preparation 
after phosphorylation of RLC (+MLCK, top 
trace). RLC phosphorylation increased the Ca2+-
  activated isometric force (from 8.3 mN/mm2 
to 13.4 mN/mm2) and accelerated the overall 
rate of the stretch activation response.  Stelzer et al. 267
some investigators (Godt and Nosek, 1989; Szczesna 
et al., 2002; Olsson et al., 2004) but not others (Sweeney 
and Stull, 1986; Metzger et al., 1989; Sweeney et al., 
1993). The reasons for these discrepancies are not 
known but may involve differences in the basal levels 
of RLC phosphorylation in the various experimental 
preparations used.
The effects of RLC phosphorylation to increase force 
at all levels of activation can be explained by increased 
proximity of the myosin heads to actin, as discussed 
above, which would increase the probability of binding 
and thereby increase force. The effects of phosphoryla-
tion were most pronounced at low levels of activation, 
where there are relatively few strongly bound cross-
bridges and the activation of force exhibits greatest co-
operativity (for review see Moss et al., 2004). In these 
cases, the greater proximity of myosin to the thin fi  la-
ments would facilitate cooperative binding of cross-
bridges to actin, which would be manifested as the 
observed increases in force at low [Ca2+] and the de-
crease in the steepness of the force–pCa relationship.
The observation that RLC phosphorylation increased 
resting force in skinned myocardium can also be 
Figure 5.  Effect of RLC phosphorylation on stretch activation re-
sponses of murine skinned myocardium at various levels of Ca2+ 
activation. The force responses of murine myocardium to a sud-
den stretch of 1% of muscle length were recorded before MLCK 
treatment (−MLCK, top) and after MLCK treatment (+MLCK, 
bottom). In each case, the force responses were normalized to the 
prestretch isometric force (corresponding to the zero baseline) 
recorded at the same level of Ca2+ activation, i.e., pCa 4.5 in A 
and D, pCa 5.75 in B and E, and pCa 5.85 in C and F.
Figure 6.  Effect of RLC phosphorylation on the stretch activa-
tion response of murine skinned myocardium. (A) Force re-
sponses to a stretch of 1% of muscle length were recorded at pCa 
5.75 before and after treatment of myocardium with MLCK. All 
transients are normalized to prestretch force, which corresponds 
to the zero baseline. Apparent rate constants of force decay (krel) 
and delayed force development (kdf) were 224 s−1 and 17.2 s−1 be-
fore MLCK treatment and 178 s−1 and 32.7 s−1 after MLCK treat-
ment, respectively. (B) Force responses to a stretch of 1% of 
muscle length were recorded at equivalent activation levels (i.e., 
P/Po  50% of maximal) before and after treatment of myocar-
dium with MLCK. Nonphosphorylated trace is the same as in A, 
and apparent rate constants of force decay (krel) and delayed 
force development (kdf) were 182 s−1 and 23.2 s−1 after MLCK 
treatment, respectively.268 Regulatory Light Chain Phosphorylation in Murine Myocardium
  explained on the basis of an increased probability of 
cross-bridge binding. The increase in resting force in 
cardiac (but not in skeletal) muscle presumably mani-
fests the signifi  cantly greater thin fi  lament–activating 
effects of strong binding cross-bridges in cardiac muscle 
(Fitzsimons et al., 2001b).
Effects of RLC Phosphorylation on Stretch Activation 
of Murine Myocardium
Stretch activation is a feature of all oscillatory muscles 
(Pringle, 1978; Steiger, 1977), and in mammals it ap-
pears that this property of myocardium generates addi-
tional power to help propel systolic ejection (Poetter 
et al., 1996; Vemuri et al., 1999; Davis et al., 2001). Here 
we show that increased phosphorylation of RLC signifi  -
cantly accelerates the overall rate of the stretch activa-
tion response in murine ventricular myocardium.
When contracting muscle is suddenly stretched to a 
new isometric length, the resulting force transient con-
sists of three distinct phases: an initial increase force 
(phase 1) coincident with the stretch that is presumably 
due to increased strain of attached cross-bridges  (Huxley 
and Simmons, 1971), a subsequent rapid decay in force 
(phase 2) as highly strained cross-bridges are forc  ibly 
detached, and a delayed development of force (phase 3) 
to levels greater than the prestretch force due to 
attachment of new cross-bridges (Davis and Rodgers, 
1995; Piazzesi et al., 1997). Ultimately, force declines 
to a level appropriate to the new muscle length. Similar 
to previous fi  ndings in slow-twitch skeletal muscle fi  bers 
(Davis et al., 2002a, b), phosphorylation of RLC de-
creased the extent, i.e., greater P2 (Figs. 5–7), and 
slowed the rate of force decay (krel) (Fig. 7) in phase 2 
Figure 7.  Effect of RLC phosphorylation on krel and P2 at differ-
ent levels of Ca2+ activation. (A) krel values and (B) P2 values nor-
malized to prestretch isometric force are plotted as a function 
of pCa in skinned myocardium before treatment (fi  lled circles, 
n = 10) and after treatment (open circles, n = 10) with MLCK. 
The data shown were obtained from force responses to stretches 
of 1% of muscle length. Data are means ± SEM.
Figure 8.  Effect of RLC phosphorylation on Pdf and kdf at differ-
ent levels of Ca2+ activation. (A) Pdf values normalized to pre-
stretch isometric force and (B) kdf values are plotted as a function 
of pCa in skinned myocardium both before treatment (fi  lled 
  circles, n = 10) and after treatment with MLCK (open circles, 
n = 10). The data shown were obtained from force responses 
to stretches of 1% of muscle length. Data are means ± SEM.  Stelzer et al. 269
of the force transients in skinned myocardium. It is 
likely that an increase in probability of cross-bridge at-
tachment to actin accounts for the slowing of krel and 
the increase in P2 after RLC phosphorylation. Such a 
mechanism would result in faster cross-bridge attach-
ment even during the phase of force decay, such that 
the rate of decay would be slowed. In this case, changes 
in the rates of force decay (krel) and force recovery (kdf) 
may govern the amplitude of P2, which is the transition 
point at which the cross-bridge recruitment phase be-
gins to dominate the cross-bridge detachment phase 
(Campbell et al., 2004). Because phosphorylation of 
RLC decreases the rate of force decay and simultane-
ously accelerates force recovery, the difference in 
rates of the two phases decreases, which increases the 
value of P2.
A critical feature of the stretch activation response is 
delayed force development, which has been associated 
with the generation of power during contraction (Kawai 
et al., 1993). In this regard, mutations in the regulatory 
domain of myosin, which binds the essential and regula-
tory light chains, alter the stretch activation responses 
and power output of insect muscles (Tohtong et al., 
1995) and mouse myocardium (Vemuri et al., 1999). In 
the context of the present study, the effects of RLC 
phosphorylation on contraction could be manifested as 
changes in the amount of force produced at a given 
[Ca2+], in the numbers of additional cross-bridges re-
cruited by stretch (P3), a change in the rate of delayed 
force development (kdf), or both.
The amplitude (P3) of the delayed force transient 
normalized to prestretch force is inversely related to 
level of activation, i.e., it is smaller at higher levels of ac-
tivation (Linari et al., 2004; Stelzer et al., 2006b), pre-
sumably because there are fewer unbound cross-bridges 
available for recruitment to force-generating states. In 
this study, P3 was slightly reduced by RLC phosphoryla-
tion (Fig. 6), suggesting that fewer cross-bridges were 
recruited as a result of stretch. This result can be ex-
plained by the fact that phosphorylation increases the 
Ca2+ sensitivity of force, i.e., increases the number of 
cross-bridges bound at a given level of Ca2+ activation, 
so that at each level of activation fewer cross-bridges are 
available for recruitment due to stretch.
While the decrease in amplitude of delayed force with 
RLC phosphorylation would by itself depress contrac-
tile function, the dramatic acceleration of delayed force 
development observed at all levels of activation would 
be expected to enhance contractile function. The in-
creased proximity of myosin heads with actin after RLC 
phosphorylation (Sweeney et al., 1994; Levine et al., 
1998) would increase the probability of cross-bridge in-
teraction with actin and thereby accelerate the rate of 
force development. We have previously suggested (Stelzer 
et al., 2006b) that the activation dependence of the 
rate constant of delayed force development (kdf) in mu-
rine myocardium is due in part to a decrease in the co-
operative recruitment of cross-bridges at high levels of 
activation because fewer cross-bridges are available for 
recruitment in response to stretch. This would have the 
effect of accelerating kdf at these levels of activation 
(Moss et al., 2004). Conversely, at low levels of activa-
tion, a relatively small fraction of available cross-bridges 
is strongly bound to actin, leaving a larger number of 
myosin heads for recruitment upon stretch, which would 
slow the overall rate of force development (Campbell, 
1997). Thus, the greater acceleration of delayed force 
development with RLC phosphorylation at submaximal 
[Ca2+] is presumably due to either an acceleration of 
cooperative recruitment of cross-bridges by stretch or a 
reduction in the amplitude of this process. Either mech-
anism is consistent with the apparent elimination of the 
slower phase of delayed force development due to RLC 
phosphorylation (Table II).
The effect of RLC phosphorylation on kdf was most 
prominent at low levels of activation where large ac-
celerations in the rates of delayed force development 
were observed, suggesting that cooperative activation or 
transitions of cross-bridges to strongly bound force-gener-
ating states or both were accelerated. As Ca2+ activation 
TABLE II
Effect of MLCK Treatment on the Ca2+ Activation Dependence of the Phase 3 Delayed Force Increase in Murine Myocardium
Group pCa kdf ak 1 bk 2
s−1 s−1 s−1
−MLCK 4.5 41.8  ± 2.1 1.00  41.0 ± 2.4 – –
+MLCK 47.8 ± 1.7a 1.00  48.9 ± 2.5a ––
−MLCK 5.75 17.2 ± 1.5 0.62 ± 0.03 28.5 ± 1.8 0.38 ± 0.03 4.0 ± 0.7
+MLCK  35.4 ± 1.3a  1.00a  36.1 ± 1.7a  – –
−MLCK 5.85 9.9 ± 1.1 0.48 ± 0.03 20.5 ± 1.6 0.52 ± 0.03 2.1 ± 0.4
+MLCK 24.7 ± 1.1a  1.00a  25.3 ± 1.4a  – –
Data are means ± SEM, from 10 preparations subjected to a sudden stretch of 1% of muscle length. Apparent rate constants for the phase 3 delayed force 
increase were obtained either from conversion of half times of force recovery (kdf) or by fi  tting a double exponential to each record, y = a · exp(−k1 · x) + 
b · exp(−k2 · x), where “a” and “b” are the amplitudes of the fast and slow phases, respectively.
aSignifi  cantly different from value obtained −MLCK, P < 0.05.270 Regulatory Light Chain Phosphorylation in Murine Myocardium
was increased, the effects of RLC phosphorylation to 
ac  celerate force development became less pronounced 
but were still signifi  cant even at maximal levels of Ca2+ 
activation where relatively little cooperative recruitment 
of cross-bridges would be expected (Fig. 8). However, 
even at maximal activation, it seems likely that some un-
bound cross-bridges are still available for recruitment, 
since incubating skinned skeletal or cardiac muscles 
with a nonforce-generating, derivative of myosin S1 
(NEM-S1) can produce rates of force development 
that are faster than those recorded at saturating Ca2+ 
in the absence of NEM-S1 (Fitzsimons et al., 2001a,b). 
  Increased levels of Mg ATPase activity at maximal 
Ca2+ activations have also been observed with MLCK-
  mediated RLC phosphorylation of murine skinned 
myocardium (Sanbe et al., 1999). Thus, the present 
results indicate that the kinetics of cross-bridge cycling 
measured during maximal Ca2+ activations are not truly 
maximal since the overall rate of the stretch activation 
response can be accelerated by RLC phosphorylation. 
As discussed earlier, the increase in maximal force 
due to RLC phosphorylation indicates that additional 
cross-bridges are bound, which could accelerate or 
eliminate cooperative recruitment of cross-bridges to 
force-  generating states.
Phosphorylation of RLC appears to affect the stretch 
activation response differently across muscle types and 
species. For example, mutating the phosphorylation 
sites in RLC of Drosophila indirect fl  ight muscle from 
serines to nonphosphorylatable alanines decreased os-
cillatory power (Tohtong et al., 1995; Dickinson et al., 
1997) by decreasing the amplitude of stretch activation 
but without altering cross-bridge kinetic rates. In con-
trast, the amplitude (P3) of stretch activation in mam-
malian slow skeletal fi  bers (Davis et al., 2002b) and 
murine myocardium (present study) is decreased by 
RLC phosphorylation, while the rate of force develop-
ment (kdf) is slightly increased in slow skeletal muscle 
and dramatically increased in myocardium. Despite 
these differences in the effects of RLC phosphorylation 
on stretch activation amplitude and kinetics, an inter-
pretation common to the above studies is that RLC 
phosphorylation slows cross-bridge detachment and/or 
facilitates cross-bridge attachment so that more cross-
bridges contribute to force development.
With regard to possible direct effects of RLC phos-
phorylation on steps in the cross-bridge cycle, Davis 
et al. (2002b) have suggested that actin-induced phos-
phate release from the weakly bound state is acceler-
ated, thereby increasing the number of cross-bridges 
entering the contractile cycle. This idea is based on 
their observation that RLC phosphorylation reverses 
the accumulation of cross-bridges in weakly bound 
states due to treatment of skeletal muscle fi  bers with 
2,3-butanedione monoxime (BDM). Thus, RLC phos-
phorylation speeds the transitions between weakly 
bound or low force states to strongly bound high force 
states (accelerates kdf), and slows the transition from the 
high force to the weakly bound states (decelerates krel), 
thereby favoring the strongly bound state and force 
generation. The decreased amplitudes of force decay 
(i.e., increased P2) and of the peak-to-trough excursion 
of phase 3 (Pdf) observed in the present study are con-
sistent with this idea.
Possible Roles of RLC Phosphorylation in Cardiac Function
Previous studies show that a gradient of RLC phos-
phorylation exists in the murine heart (Davis et al., 
2001; Davis et al., 2002a), such that the epicardium is 
hyperphosphorylated and the endocardium is hypo-
phosphorylated. The greater torsional strain of the en-
docardium as compared with the epicardium during 
systole (Bogaert and Rademakers, 2001) suggests that 
regional differences in RLC phosphorylation control 
the timing of force production across the ventricular 
wall. RLC phosphorylation enhances cardiac contrac-
tion by mediating a substantial increase in the ability of 
myocardium to produce force at a given level of Ca2+, 
thereby increasing the amount of work produced dur-
ing each beat. Based on our results and as predicted by 
Davis et al. (2001), epicardial myocardium with higher 
levels of RLC phosphorylation would produce more 
force and exhibit accelerated stretch activation with 
diminished amplitude compared with endocardial 
myocardium. Therefore, while endocardial fi  bers are 
arranged in a right-handed helical formation and epi-
cardial fi  bers in an opposing left-handed helical for-
mation (Streeter et al., 1969), ventricular torsional 
twist during systole proceeds in the direction of the 
epicardial fi  bers (Epstein and Davis, 2006) such that 
the endocardium is forcibly strained by epicardial fi  -
bers to produce delayed stretch activation of the endo-
cardium. Indeed, recent evidence shows that despite 
being activated fi   rst, the endocardium is actively 
stretched by the epicardium later in systole (Nickerson 
et al., 2005; Buckberg et al., 2006). Thus, the phos-
phorylation state of RLC is a determinant of the stretch 
activation response of myocardium and thereby ap-
pears to contribute to work production during ventric-
ular systole. Furthermore, the fi   ndings that RLC 
phosphorylation levels are decreased in end-stage hu-
man heart failure (van der Velden et al., 2003) suggest 
that the timing of force generation and work produc-
tion is disrupted and contributes to depressed systolic 
function in this disease.
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